Drugs / IIV4c
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03165617 | May 2017 → Sep 2019 | influenza | Seqirus | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IIV4c | “We evaluated the efficacy of a cell-culture-derived quadrivalent inactivated influenza vaccine (IIV4c) using a Madin-Darby canine kidney cell line in children and adolescents 2...” PMID 34644472 ↗ Oct 2021 |
| Known as | QIVc | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03165617 ↗ |
| Modality | Vaccine | “Cell-derived Quadrivalent Influenza Vaccine” NCT03165617 ↗ |
| Route | Intramuscular | “Cell-derived Quadrivalent Influenza Vaccine for intramuscular use” NCT03165617 ↗ |